Forest Laboratories Inc

Forest Laboratories nears $3B takeover deal of Aptalis

Forest Laboratories is close to an agreement to buy New Jersey-based specialty pharmaceutical company Aptalis Holdings from private equity firm TPG Capital. Forest will pay $3 billion for Aptalis.

Read Full Article

Forest Labs to buy schizophrenia drug, cut costs

Forest Laboratories Inc, which is facing patent expirations on several of its biggest drugs, on Monday said it plans to buy rights to a new schizophrenia treatment from Merck & Co and cut annual operating costs by $500 million in fiscal 2016.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics